ID   00-143
AC   CVCL_D1GY
DR   Wikidata; Q127378545
RX   PubMed=11733348;
RX   PubMed=21447744;
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT (PubMed=11733348; PubMed=21447744).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
RX   PubMed=11733348; DOI=10.1016/S0002-9440(10)63049-0; PMCID=PMC1850578;
RA   French C.A., Miyoshi I., Aster J.C., Kubonishi I., Kroll T.G.,
RA   Dal Cin P.S., Vargas S.O., Perez-Atayde A.R., Fletcher J.A.;
RT   "BRD4 bromodomain gene rearrangement in aggressive carcinoma with
RT   translocation t(15;19).";
RL   Am. J. Pathol. 159:1987-1992(2001).
//
RX   PubMed=21447744; DOI=10.1158/0008-5472.CAN-10-3513; PMCID=PMC3070805;
RA   Schwartz B.E., Hofer M.D., Lemieux M.E., Bauer D.E., Cameron M.J.,
RA   West N.H., Agoston E.S., Reynoird N., Khochbin S., Ince T.A.,
RA   Christie A.L., Janeway K.A., Vargas S.O., Perez-Atayde A.R., Aster J.C.,
RA   Sallan S.E., Kung A.L., Bradner J.E., French C.A.;
RT   "Differentiation of NUT midline carcinoma by epigenomic
RT   reprogramming.";
RL   Cancer Res. 71:2686-2696(2011).
//